Breast Cancer Female Clinical Trials in Boston, Massachusetts
5 recruitingBoston, Massachusetts
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer
Breast CancerMetastatic Breast CancerBreast Cancer Female+2 more
Kristina A. Fanucci65 enrolled1 locationNCT07198724
Recruiting
Not Applicable
TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients
Breast CancerBreast Cancer FemaleStage III Breast Cancer+2 more
Dana-Farber Cancer Institute270 enrolled3 locationsNCT05535192
Recruiting
Not Applicable
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
Breast CancerBreast Cancer Female
Dana-Farber Cancer Institute46 enrolled2 locationsNCT06322888
Recruiting
Phase 2
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
Breast CancerBreast Cancer FemaleHER2-Negative Breast Carcinoma+4 more
Sarah Sammons, MD58 enrolled3 locationsNCT06176261
Recruiting
Phase 2
The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer
Breast CancerBreast Cancer MetastaticBreast Cancer Female+3 more
Dana-Farber Cancer Institute72 enrolled1 locationNCT06439693